Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death–induced Lung Injury in Pigs
Authors:
- 1 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 206 (5) , 584-595
Abstract
Rationale: Donor brain death–induced lung injury may compromise graft function after transplantation. Establishing strategies to attenuate lung damage remains a challenge because the underlying mechanisms remain uncertain. Objectives: The effects of tacrolimus pretreatment were evaluated in an experimental model of brain death–induced lung injury. Methods: Brain death was induced by slow intracranial infusion of blood in anesthetized pigs after randomization to tacrolimus (orally administered at 0.25 mg ⋅ kg−1 twice daily the day before the experiment and intravenously at 0.05 mg ⋅ kg−1 1 h before the experiment; n = 8) or placebo (n = 9) pretreatment. Hemodynamic measurements were performed 1, 3, 5, and 7 hours after brain death. After euthanasia of the animals, lung tissue was sampled for pathobiological and histological analysis, including lung injury score (LIS). Measurements and Main Results: Tacrolimus pretreatment prevented increases in pulmonary arterial pressure, pulmonary vascular resistance, and pulmonary capillary pressure and decreases in systemic arterial pressure and thermodilution cardiac output associated with brain death. After brain death, the ratio of PaO2 to Fi O2 decreased, which was prevented by tacrolimus. Tacrolimus pretreatment prevented increases in the ratio of IL-6 to IL-10, VCAM1 (vascular cell adhesion molecule 1), circulating concentrations of IL-1β, and glycocalyx-derived molecules. Tacrolimus partially decreased apoptosis (Bax [Bcl2-associated X apoptosis regulator]–to–Bcl2 [B-cell lymphoma-2] ratio [P = 0.07] and number of apoptotic cells in the lungs [P < 0.05]) but failed to improve LIS. Conclusions: Immunomodulation through tacrolimus pretreatment prevented pulmonary capillary hypertension as well as the activation of inflammatory and apoptotic processes in the lungs after brain death; however, LIS did not improve.Keywords
Funding Information
- Belgian Foundation for Cardiac Surgery
- Fondation Mont-Godinne
- Fondation Mont-Godinne
- Belgian Foundation for Cardiac Surgery
- Fondation Mont-Godinne
- Fondation Mont-Godinne
This publication has 48 references indexed in Scilit:
- Increased levels of interleukin-1β and tumor necrosis factor-α in donor lungs rejected for transplantationThe Journal of Heart and Lung Transplantation, 2011
- Synergistic Protection in Lung Ischemia-Reperfusion Injury With Calcineurin and Thrombin InhibitionThe Annals of Thoracic Surgery, 2010
- Endothelin-1 Impairs Alveolar Epithelial Function via Endothelial ETB ReceptorAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Hemodynamic Resuscitation With Arginine Vasopressin Reduces Lung Injury After Brain Death in the Transplant DonorTransplantation, 2008
- Early Hemodynamic Injury During Donor Brain Death Determines the Severity of Primary Graft Dysfunction after Lung TransplantationAmerican Journal of Transplantation, 2007
- Time-Dependent Changes in Donor Brain Death Related ProcessesAmerican Journal of Transplantation, 2006
- The Hemodynamic Mechanisms of Lung Injury and Systemic Inflammatory Response Following Brain Death in the Transplant DonorAmerican Journal of Transplantation, 2005
- Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial HypertensionCirculation, 2003
- Myocardial damage secondary to brain lesionsAmerican Heart Journal, 1969
- Neurohemodynamics of Pulmonary EdemaCirculation, 1952